HEALTH

This new vaccine made in India, ZyCoV-D, which will be injected without injection(2022)

how many doses will have to be taken?

Drugmaker Zydus has started supplying its three-dose COVID-19 vaccine ‘ZyCoV-D’ to the Government of India. The company also said in a statement that Zydus plans to make the vaccine available in the private market.

This vaccine from Ahmedabad-based Zydus Cadila was approved by the government on August 20 last year. Earlier, Zydus had tested the vaccine on 28 thousand volunteers. The specialty of this three-dose vaccine is that it does not use injections, but these vaccines are needle-free.

zycov-d

zycov-d vaccine news update 2022

There is something special in this corona vaccine, which is being said to be safe for children. This is the first plasmid DNA vaccine. Along with this, it will be applied with the help of pharma technology without the help of a needle, which will reduce the risk of side effects.

The third phase trial of Zydus Cadila’s corona vaccine ZyCoV-D has been done. It was attended by 28 thousand participants. This is now the biggest trial of any vaccine in India so far, its results have also been said to be satisfactory. During the second corona wave, its trial was conducted at 50 clinical sites in the country. It is said to be effective on the Delta variant as well.

Zydus Cadila’s zycov-d corona vaccine seems to be without a needle

The study found that Zydus Cadila’s ZyCoV-D corona vaccine is safe for children aged 12 to 18 years. It was found in the Pharmajet needleless technology study that Zydus Cadila’s ZyCoV-D corona vaccine is safe for children aged 12 to 18 years. By clicking the button on the PharmaJet needle-free applicator machine, the vaccine medicine reaches inside the body.

How effective is Zykov-D – zycov d efficacy

Zydus Cadila claims that the efficacy of this vaccine is 66.60 percent. This three-dose vaccine can be given at intervals of four weeks. It can be stored at 2-8 degrees temperature. It is a plasmid DNA vaccine. This is a needle-free vaccine, which can be given through a jet injector. The company has planned that it will produce 10-12 crore doses annually.

This is India’s second indigenous vaccine. Earlier, Bharat Biotech’s vaccine has been administered to the people. At present, five vaccines have been approved in the country. Zykov-D is the fifth vaccine after Covishield, Covaccine, Sputnik, Moderna.

No hassle of cloud storage

Another good thing with ZyCoV-D is that the temperature does not have to be kept too low to keep it, which means it has good thermostability. Due to this, there will be no hassle of the cold chain, etc., due to the lack of which till now the vaccine was being wasted. Making the vaccine on the plasmid DNA platform makes it easier. It requires minimal biosafety. Along with this, there is no problem with vector-related immunity.

What is Plasmid Based DNA Vaccine

Plasmid-based DNA vaccine works by enhancing antigen-specific immunity, which helps in fighting infection. The biggest advantage of having a Plasmid DNA vaccine is that it can be kept at a temperature of 2-8 degrees. India’s second corona vaccine is made in the Covaxin Bio-Safety Level 3 Lab. At the same time, the Zydus vaccine can be made in the Level 1 lab only.

Muhammed Hashim

I am Muhammad Hashim an admin of shikshaportal.in an educational blog I belong to the Rajasthan state of India As far as my educational background is concerned, I studied of M.com pre in Badm from Rajasthan university My schooling has been passed out 10, 12 from khandela vidhyapeet Currently, I am operating my own business, and additionally, I m investing my precious time in blogging

Leave a Reply

Your email address will not be published.

Back to top button